Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel M. Keller is active.

Publication


Featured researches published by Daniel M. Keller.


Oncology Times UK | 2014

Newly IDʼd Mechanism of Metastasis Argues for Early Systemic Therapy in High-Risk Melanoma

Daniel M. Keller

A National Cancer I n s t i t u t e f u n d e d multi-site study is lending evidence to the idea that multidisciplinary cancer care improves patient care processes and patient outcomes. The Multidisciplinary Care Research Project, undertaken by the NCI Community Cancer Centers Program (NCCCP), investigated whether specific elements of multidisciplinary care—for example, case planning or care coordination—appear to influence treatment decisions, overall survival, and care processes such as time to initial treatment. First-in-Kind Study Documents Improved Outcomes with Multidisciplinary Care


Oncology Times UK | 2010

Proton beam radiation – the ‘chicken and egg’ dilemma, Part 2

Daniel M. Keller

With little data from randomised controlled trials d e m o n s t r a t i n g b e t t e r efficacy or lower adverse effects, medical centres continue to build and open new proton beam radiation therapy (PBRT) facilities. At costs of between


Oncology Times UK | 2009

From Shotgun to Gatling Gun: Multibarreled Approach to Cancer Treatment

Daniel M. Keller

100 million (£65 million) and


Oncology Times UK | 2014

Melanoma: Engineered Herpes Virus Effective in Treating Local and Distant Lesions

Daniel M. Keller

225 million (£160 million) each facility, more research into the relative efficacy and safety of PBRT compared with current photon (X-ray) therapies is needed and planned.


Oncology Times UK | 2014

Biomarkers and Combination Therapies Called Next Big Steps in Melanoma Treatment

Daniel M. Keller


Oncology Times UK | 2014

Anti-PD-L1 Antibody Continues to Show Good Activity Against Melanoma, with Low Toxicity

Daniel M. Keller


Oncology Times UK | 2014

Update from Lynn Schuchter on the Fertile Field of Melanoma Treatments

Daniel M. Keller


Oncology Times UK | 2014

In Phase IB Trial in Advanced Melanoma, MK-3475 Shows 81% Overall Survival Rate

Daniel M. Keller


Oncology Times UK | 2014

James Doroshow on How NCI is Facilitating Drug-Discovery Combinations/Collaborations

Daniel M. Keller


Oncology Times UK | 2011

Making a ‘Rapid-Learning System’ Work for Cancer Care

Daniel M. Keller

Collaboration


Dive into the Daniel M. Keller's collaboration.

Researchain Logo
Decentralizing Knowledge